These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2012737)

  • 1. Effect of superparamagnetic particles in agarose gels. A magnetic resonance imaging study.
    Ericsson A; Lönnemark M; Hemmingsson A; Bach-Gansmo T
    Acta Radiol; 1991 Jan; 32(1):74-8. PubMed ID: 2012737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferrimagnetic susceptibility contrast agents.
    Bach-Gansmo T
    Acta Radiol Suppl; 1993; 387():1-30. PubMed ID: 8390776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of oral magnetic particles in MR imaging of the abdomen with spin-echo and gradient-echo sequences.
    Boudghène FP; Bach-Gansmo T; Grange JD; Lame S; Nantois C; Wallays C; Bigot JM
    J Magn Reson Imaging; 1993; 3(1):107-12. PubMed ID: 8428075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superparamagnetic iron oxide for liver imaging. Comparison among three different preparations.
    Bach-Gansmo T; Fahlvik AK; Ericsson A; Hemmingsson A
    Invest Radiol; 1994 Mar; 29(3):339-44. PubMed ID: 8175309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
    Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
    AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck.
    Anzai Y; McLachlan S; Morris M; Saxton R; Lufkin RB
    AJNR Am J Neuroradiol; 1994 Jan; 15(1):87-94. PubMed ID: 7511324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement.
    Guimaraes R; Clément O; Bittoun J; Carnot F; Frija G
    AJR Am J Roentgenol; 1994 Jan; 162(1):201-7. PubMed ID: 8273666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence.
    Chambon C; Clement O; Le Blanche A; Schouman-Claeys E; Frija G
    Magn Reson Imaging; 1993; 11(4):509-19. PubMed ID: 8316064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal alterations, artifacts and image distortion induced by a superparamagnetic contrast medium. A phantom study in a 0.3 tesla MR system.
    Holtås S; Wallengren NO; Ericsson A; Bach-Gansmo T
    Acta Radiol; 1990 Mar; 31(2):213-6. PubMed ID: 2372467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of hyoscine butylbromide in abdominal MR imaging with and without oral magnetic particles.
    Laniado M; Grönewäller E; Kopp AF; Kaminsky SF; Hamm B; Jacobsen TF; Claussen CD
    Abdom Imaging; 1997; 22(4):381-8. PubMed ID: 9157855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral magnetic particles in MR imaging of the abdomen and pelvis.
    Rinck PA; Smevik O; Nilsen G; Klepp O; Onsrud M; Oksendal A; Børseth A
    Radiology; 1991 Mar; 178(3):775-9. PubMed ID: 1994417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Superparamagnetic iron particles. The clinical results in the MR diagnosis of liver metastases].
    Ham B; Reichel M; Vogl T; Taupitz M; Wolf KJ
    Rofo; 1994 Jan; 160(1):52-8. PubMed ID: 8305693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gradient echo acquisition for superparamagnetic particles with positive contrast (GRASP): sequence characterization in membrane and glass superparamagnetic iron oxide phantoms at 1.5T and 3T.
    Mani V; Briley-Saebo KC; Itskovich VV; Samber DD; Fayad ZA
    Magn Reson Med; 2006 Jan; 55(1):126-35. PubMed ID: 16342148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure activity relationship of magnetic particles as MR contrast agents.
    Thomassen T; Wiggen UN; Gundersen HG; Fahlvik AK; Aune O; Klaveness J
    Magn Reson Imaging; 1991; 9(2):255-8. PubMed ID: 2034059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of an oral magnetic particle formulation as a gastrointestinal contrast agent for magnetic resonance imaging.
    Rubin DL; Muller HH; Young SW; Hunke WA; Gorman WG
    Invest Radiol; 1994 Jan; 29(1):81-6. PubMed ID: 8144343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T1-weighted magnetic resonance imaging sequence appropriate for the evaluation of the longitudinal relaxation effect of superparamagnetic iron oxide: a phantom study.
    Takahama K; Amano Y; Hayashi H; Kumazaki T;
    J Nippon Med Sch; 2002 Dec; 69(6):571-6. PubMed ID: 12646990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superparamagnetic particles as an MRI contrast agent for the gastrointestinal tract.
    Lönnemark M; Hemmingsson A; Carlsten J; Ericsson A; Holtz E; Klaveness J
    Acta Radiol; 1988; 29(5):599-602. PubMed ID: 3166884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dextran magnetite as a liver contrast agent.
    Magin RL; Bacic G; Niesman MR; Alameda JC; Wright SM; Swartz HM
    Magn Reson Med; 1991 Jul; 20(1):1-16. PubMed ID: 1943651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of spatial distribution on proton relaxation enhancement by particulate iron oxide.
    Tanimoto A; Pouliquen D; Kreft BP; Stark DD
    J Magn Reson Imaging; 1994; 4(5):653-7. PubMed ID: 7526912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relaxation enhancement of the dog liver and spleen by biodegradable superparamagnetic particles in proton magnetic resonance imaging.
    Hemmingsson A; Carlsten J; Ericsson A; Klaveness J; Sperber GO; Thuomas KA
    Acta Radiol; 1987; 28(6):703-5. PubMed ID: 2962602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.